Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape
About This Grant
ABSTRACT Biomolecular delivery is foundational to modern biology and medicine, offering precise control over cell behavior through surface receptor engagement and intracellular delivery of genes and proteins. Yet this potential is fundamentally limited by biological barriers, including tight junctions, plasma membranes, and endosomal compartments, that restrict transport, uptake, and cytosolic access. My lab specializes in modular biomaterial platforms for programmable ligand display and light-triggered intracellular release. We will leverage these precision tools to investigate how nanoscale features influence delivery mechanisms at the molecular and cellular scales. Theme 1: Can Nanoscale Engineering of Integrin Clustering Induce Transient Tight Junction Opening? Tight junctions are a major barrier to tissue-level delivery of large biologics, particularly across epithelial and endothelial interfaces. Previous work from our group demonstrated that nanotopographic cues remodel tight junctions via integrin signaling. Here, we hypothesize that spherical particles displaying nanoscale-clustered RGD ligands or integrin-targeting antibodies can recapitulate this remodeling effect without physical topography. Using our DNA-scaffolded ligand display system, we will systematically vary density, spacing, and flexibility to identify design rules for non-toxic, reversible tight junction modulation. This project will establish foundational principles for enhancing paracellular transport using spherical biomaterials. Theme 2: Can Ligand Architecture and Carrier Design Override Receptor-Intrinsic Internalization? While receptor- mediated endocytosis is often described as intrinsic to each receptor, growing evidence suggests that external presentation cues can redirect uptake pathways. We will apply our modular surface-engineering system to dissect how ligand architecture influences internalization for three distinct receptor systems: CD40 (clustering- driven), c-Kit (signal-dependent), and integrins (mechanosensitive). We hypothesize that tuning ligand density and flexibility on synthetic carriers can override receptor preferences, reprogramming trafficking and cargo fate. This project aims to uncover generalizable design strategies for targeted, receptor-agnostic intracellular delivery. Theme 3: Can NIR-Stimulated Nanoparticles Over Endosomal Barriers Across Cell Type and Cargos? Endosomal escape remains a major bottleneck for the intracellular delivery of therapeutic macromolecules. We previously demonstrated that hollow gold nanoshells enable siRNA release via NIR-triggered photothermal disruption. Here, we extend this strategy to mRNA and Cas9/gRNA delivery across challenging primary cell types, including primary T cells, macrophages, dendritic cells, and hematopoietic stem cells. We hypothesize that optimal escape thresholds depend on both cargo physicochemical properties and cell-intrinsic membrane repair capacity. By mapping delivery efficiency across cargo and cell types, we aim to define tunable parameters for safe and efficient endosomal release. Altogether, this program will generate broadly applicable principles for biologic delivery while training students across biomaterials, cellular analysis, and advanced imaging.
Grant Summary
Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape is a NIGMS - National Institute of General Medical Sciences grant providing up to $362K for university, nonprofit, healthcare org. Applications are due 2031-03-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $362K
2031-03-31
- 1Confirm your organization is eligible for Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape from NIGMS - National Institute of General Medical Sciences, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIGMS - National Institute of General Medical Sciences before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIGMS - National Institute of General Medical Sciences's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape: Frequently Asked Questions
Who is eligible for the Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape?
Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape is offered by NIGMS - National Institute of General Medical Sciences and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape provide?
Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape provides up to $362K per award from NIGMS - National Institute of General Medical Sciences. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape deadline?
Applications for Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape are due 2031-03-31 (open). Because deadlines can change, verify the date with the funder, NIGMS - National Institute of General Medical Sciences, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape?
To apply for Nanoscale control of ligand display & release to probe barrier modulation, targeted internalization, and endosomal escape, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIGMS - National Institute of General Medical Sciences.